We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 37

Former Innospec Inc executive charged
  • Dorsey & Whitney LLP
  • United Kingdom, USA
  • November 18 2011

Former Innospec Inc executive, Dr David Turner, was charged at a London court for allegedly bribing Iraqi and Indonesian officials between 2002 and 2008 to secure government contracts


Smith & Nephew
  • Dorsey & Whitney LLP
  • USA
  • February 20 2012

The Securities and Exchange Commission (SEC) announced that it has reached a settlement with London-based medical device company Smith & Nephew PLC to resolve charges that the company violated the Foreign Corrupt Practices Act (FCPA) when its U.S. and German subsidiaries bribed public doctors in Greece for over a decade in order to win business


Armor Holdings, Inc.
  • Dorsey & Whitney LLP
  • USA
  • July 27 2011

Armor Holdings, Inc. (“Armor”), the maker of military trucks, has agreed to pay $16 million to resolve claims that it bribed a United Nations official to win contracts connected to peacekeeping missions


Parker Drilling Co.
  • Dorsey & Whitney LLP
  • USA
  • July 27 2011

A federal judge dismissed a case against Parker Drilling in which a shareholder accused executives of bribing officials in Kazakhstan and Nigeria


Eli Lilly & Co
  • Dorsey & Whitney LLP
  • USA
  • June 24 2011

In an effort to solicit members for a class action, two law firms that represent shareholders in class actions against publicly traded companies are investigating certain officers and directors of Eli Lilly


Noble Corporation
  • Dorsey & Whitney LLP
  • USA
  • June 22 2012

In February 2012, the SEC brought FCPA claims against three oil services executives associated with Noble Corporation: Thomas O’Rourke, Mark Jackson and James Ruehlen


SEC investigating Bristol-Myers Squibb
  • Dorsey & Whitney LLP
  • USA
  • May 17 2012

Bristol-Myers Squibb has confirmed that the SEC is investigating its sales and marketing practices in various countries


Citigroup global marks, inc
  • Dorsey & Whitney LLP
  • USA
  • December 22 2011

The Commission appealed the determination by District Court Judge Rakoff to not approve the proposed settlement in this case


False audit opinion
  • Dorsey & Whitney LLP
  • USA
  • December 22 2011

In the Matter of Kempisty & Co., CPAs, P.C., Adm. Proc. File No. 3344 (Dec. 14, 2011) is a proceeding against the audit firm, its founding partner Philip Kempisty, and an employee of the firm, John Rubino


Biomet Inc.
  • Dorsey & Whitney LLP
  • USA
  • April 16 2012

Medical device company Biomet has agreed to pay more than $22 million to settle charges by the Securities and Exchange Commission (SEC) as well as parallel criminal charges by the U.S. Department of Justice (DOJ